SA58 Nasal Spray
Sponsors
Sinovac Life Sciences Co., Ltd.
Conditions
COVID-19
Unknown Phase
Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations
NCT05664919
Start: 2022-10-30End: 2023-03-31Target: 7000Updated: 2023-01-12
Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People
NCT05667714
Start: 2022-11-26End: 2023-03-30Target: 2900Updated: 2023-01-12